rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTCGGTCAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	68	0.27755102040816326		43	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	8	5	5	1	8	23	34	38	35	46						01,02								X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01	TCRBJ02-06*01	7678A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				5	1	3	0	0	5	2	3	0	0	245	78	167	0	0	4.7431071494277667E-4	0.999525666	0.0234285686	2.26752853				90	0.0369370207	0.512820542	0.277551025	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:12	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.2	MSKCC- Snyder- P01-02		3.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTTGACCTCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	63	0.2571428571428571		50	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	8	5	23	35	48	43	53													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	7678A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				5	1	3	0	0	5	2	3	0	0	245	78	167	0	0	4.7431071494277667E-4	0.999525666	0.0234285686	2.26752853				90	0.0369370207	0.512820542	0.277551025	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:12	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.2	MSKCC- Snyder- P01-02		3.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTGAGGGCTGCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA	CASSLRAAISIRTEAFF	In	VDJ	1	40	0.16326530612244897	0.5128205128205128	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	11	0	4	2	16	26	38	45	40	61		TCRBV03-01,TCRBV03-02												CASSLRAAISIRTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	7678A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				5	1	3	0	0	5	2	3	0	0	245	78	167	0	0	4.7431071494277667E-4	0.999525666	0.0234285686	2.26752853				90	0.0369370207	0.512820542	0.277551025	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:12	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.2	MSKCC- Snyder- P01-02		3.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTAGAGTAGCGCAGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	36	0.1469387755102041		53	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-06	01	5	1	6	5	11	5	26	38	54	49	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01		TCRBJ02-06*01	7678A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				5	1	3	0	0	5	2	3	0	0	245	78	167	0	0	4.7431071494277667E-4	0.999525666	0.0234285686	2.26752853				90	0.0369370207	0.512820542	0.277551025	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:12	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.2	MSKCC- Snyder- P01-02		3.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGACAACACCGGGGAGCTGTTTTTTGGAGAA	CASSDSDNTGELFF	In	VDJ	1	38	0.15510204081632653	0.48717948717948717	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	0	1	7	2	0	0	23	-1	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDSDNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	7678A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				5	1	3	0	0	5	2	3	0	0	245	78	167	0	0	4.7431071494277667E-4	0.999525666	0.0234285686	2.26752853				90	0.0369370207	0.512820542	0.277551025	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:39:12	Age (Range):65+ Years (Old Age),Age:72 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 386,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 329,type of chemo:carbo/taxol	0.2	MSKCC- Snyder- P01-02		3.0	
